|
Dose/route
|
Neutrophils
|
Monocytes
|
Lymphocytes
|
WBCs
|
---|
Saline
|
2 ml i.p.
|
0.150 ± 0.009d
|
0.079 ± 0.010d
|
0.472 ± 0.040d
|
0.945 ± 0.0982d
|
Carrageenan
|
10 ml/kg p.o.
|
6.027 ± 0.350a
|
1.972 ± 0.136a
|
12.665 ± 1.456a
|
23.422 ± 1.556a
|
Diclofenac sodium
|
10 mg/kg p.o.
|
4.494 ± 0.172c
|
1.445 ± 0.114bc
|
10.978 ± 1.231ab
|
17.521 ± 1.201b
|
FXC
|
100 mg/kg p.o.
|
5.082 ± 0.238b
|
1.665 ± 0.125b
|
9.240 ± 0.857b
|
16.932 ± 0.974b
|
FXC
|
200 mg/kg p.o.
|
4.285 ± 0.153c
|
1.353 ± 0.122c
|
5.698 ± 0.483c
|
12.199 ± 1.571c
|
- FXC = F. xanthoxyloides chloroform fraction. Count of cells is presented as mean ± SD (n = 6). One way analysis of variance for count of cells was followed by multiple comparisons by Tukeys’ HSD test. Superscript alphabets indicate significance among treatments (P <0.001) on not sharing common letter